- Our experts develop in vitro assays in high-throughput formats to support drug discovery projects.
- We create cell-based and biochemical assays in 384-well and 1536-well plates for HTS campaigns and data collection during hit-to-lead and lead optimization, aiding preclinical advancement.
- Our technology platforms support multiple readouts, including fluorescence intensity (FRET), luminescence (BRET), absorbance, fluorescence polarization, AlphaScreen, time-resolved fluorescence, immunofluorescence, and qPCR.
- We develop assays across various target classes like GPCRs, receptor tyrosine kinases, multiple enzyme classes, protein-protein interactions, and gene expression.
- We have extensive experience in Infectious Disease drug discovery, including screening within BSL-3 containment and bringing new virus variants online for relevant results.
- Our assays are compatible with small molecules and biologics, with readouts such as cytopathic effect, reporter virus, immunofluorescence, and AlphaScreen.
- Our goal is to produce accurate results with high throughput to inform critical decisions.